PRKAA2 and urinary bladder cancer: Furthermore, phenformin enhances apoptosis in bladder cancer [53,54] and increases vulnerability in glioblastoma [55] and hepatocellular carcinoma [56,57] via AMPK-mediated nutrient deprivation.